Nisarg Soni

Dr. Nisarg Soni

Nanomaterials for Biomedical Applications, Istituto Italiano di Tecnologia, Genova, Italy
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
HGHelena Gavilán
Helena Gavilán
SASahitya Kumar Avugadda
Sahitya Kumar Avugadda
TCTamara Fernandez Cabada
Tamara Fernandez Cabada
Nisarg SoniNisarg Soni
Nisarg Soni
MCMarco Cassani
Marco Cassani
TPTeresa Pellegrino
Teresa Pellegrino
Magnetic hyperthermia (MHT) is a therapeutic modality for the treatment of solid tumors that has now accumulated more than 30 years of experience. In the ongoing MHT clinical trials for the treatment of brain and prostate tumors, iron oxide nanoparticles are employed as intra-tumoral MHT agents under a patient-safe 100 kHz alternating magnetic field (AMF) applicator. Although iron oxide nanoparticles are currently approved by FDA for imaging purposes and for the treatment of anemia, magnetic nanoparticles (MNPs) designed for the efficient treatment of MHT must respond to specific physical–chemical properties in terms of magneto-energy conversion, heat dose production, surface chemistry and aggregation state. Accordingly, in the past few decades, these requirements have boosted the development of a new generation of MNPs specifically aimed for MHT. In this review, we present an overview on MNPs and their assemblies produced via different synthetic routes, focusing on which MNP features have allowed unprecedented heating efficiency levels to be achieved in MHT and highlighting nanoplatforms that prevent magnetic heat loss in the intracellular environment. Moreover, we review the advances on MNP-based nanoplatforms that embrace the concept of multimodal therapy, which aims to combine MHT with chemotherapy, radiotherapy, immunotherapy, photodynamic or phototherapy. Next, for a better control of the therapeutic temperature at the tumor, we focus on the studies that have optimized MNPs to maintain gold-standard MHT performance and are also tackling MNP imaging with the aim to quantitatively assess the amount of nanoparticles accumulated at the tumor site and regulate the MHT field conditions. To conclude, future perspectives with guidance on how to advance MHT therapy will be provided.

8 July 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
SSSwarbhanu Sarkar
Swarbhanu Sarkar
YHYeong Su Ha
Yeong Su Ha
Nisarg SoniNisarg Soni
Nisarg Soni
GAGwang Il An
Gwang Il An
WLWoonghee Lee
Woonghee Lee
JYJeongsoo Yoo
Jeongsoo Yoo

19 August 2015 in Inorganic Chemistry
Verified
Journal Article
Closed access
ADAjit V. Dale
Ajit V. Dale
GAGwang Il An
Gwang Il An
DPDarpan N. Pandya
Darpan N. Pandya
YHYeong Su Ha
Yeong Su Ha
NBNikunj Bhatt
Nikunj Bhatt
JYJeongsoo Yoo
Jeongsoo Yoo

31 July 2023 in Chemistry of Materials
Verified
Journal Article
Open access
TSTereza Sojková
Tereza Sojková
GRGiusy M. R. Rizzo
Giusy M. R. Rizzo
AGAlessandro Di Girolamo
Alessandro Di Girolamo
SASahitya K. Avugadda
Sahitya K. Avugadda
Nisarg SoniNisarg Soni
Nisarg Soni
TPTeresa Pellegrino
Teresa Pellegrino

16 March 2022 in Small
Verified
Journal Article
Open access
SFSergio Fiorito
Sergio Fiorito
Nisarg SoniNisarg Soni
Nisarg Soni
NSNiccolo' Silvestri
Niccolo' Silvestri
RBRosaria Brescia
Rosaria Brescia
HGHelena Gavilán
Helena Gavilán
TPTeresa Pellegrino
Teresa Pellegrino
Here, the synthesis and proof of exploitation of three‐material inorganic heterostructures made of iron oxide‐gold‐copper sulfide (Fe3O4@Au@Cu2−xS) are reported. Starting with Fe3O4‐Au dumbbell heterostructure as seeds, a third Cu2−xS domain is selectively grown on the Au domain. The as‐synthesized trimers are transferred to water by a two‐step ligand exchange procedure exploiting thiol‐polyethylene glycol to coordinate Au and Cu2−xS surfaces and polycatechol–polyethylene glycol to bind the Fe3O4 surface. The saline stable trimers possess multi‐functional properties: the Fe3O4 domain, of appropriate size and crystallinity, guarantees optimal heating losses in magnetic hyperthermia (MHT) under magnetic field conditions of clinical use. These trimers have indeed record values of specific adsorption rate among the inorganic‐heterostructures so far reported. The presence of Au and Cu2−xS domains ensures a large adsorption which falls in the first near‐infrared (NIR) biological window and is here exploited, under laser excitation at 808 nm, to produce photo‐thermal heat alone or in combination with MHT obtained from the Fe3O4 domain. Finally, an intercalation protocol with radioactive 64Cu ions is developed on the Cu2−xS domain, reaching high radiochemical yield and specific activity making the Fe3O4@Au@Cu2−xS trimers suitable as carriers for 64Cu in internal radiotherapy (iRT) and traceable by positron emission tomography (PET).

26 August 2014 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DPDarpan N. Pandya
Darpan N. Pandya
NBNikunj Bhatt
Nikunj Bhatt
GAGwang Il An
Gwang Il An
YHYeong Su Ha
Yeong Su Ha
Nisarg SoniNisarg Soni
Nisarg Soni
JYJeongsoo Yoo
Jeongsoo Yoo